Effect of phosphatidylinositol 3-kinase-γ inhibitor CAY10505 in hypertension, and its associated vascular endothelium dysfunction in rats
- Author
- TYAGI, Sandeep1 ; SHARMA, Saurabh1 ; RAMJI DASS BUDHIRAJA1
[1] Department of Pharmacology, I.S.F. College of Pharmacy, G.T. Road, Moga-142 001 (Punjab), India - Source
Canadian journal of physiology and pharmacology. = Journal canadien de physiologie et pharmacologie. 2012, Vol 90, Num 7, pp 881-885, 5 p ; ref : 3/4 p
- CODEN
- CJPPA3
- ISSN
- 0008-4212
- Scientific domain
- Pharmacology drugs; Physiology, morphology
- Publisher
- National Research Council of Canada, Plattsburgh, NY
- Publication country
- United States
- Document type
- Article
- Language
- English
- Author keyword
- CAY 10505 DOCA PI3Kgamma atorvastatine dysfonction endothéliale vasculaire losartan tension artérielle moyenne
- Keyword (fr)
- Atorvastatine Endothélium Hypertension artérielle Kinase Losartan Phosphatidylinositol Rat Trouble fonctionnel Dysfonction endothéliale Récepteur AT1 de l'angiotensine II Angiotensine II Antagoniste angiotensine Composé non peptide Dérivé de l'imidazole Dérivé de la statine Dérivé du biphényle Dérivé du tétrazole Enzyme Hormone peptide Hydroxymethylglutaryl-CoA reductase Inhibiteur de l'HMG-CoA reductase Inhibiteur enzyme Mammalia Octapeptide Oxidoreductases Pathologie de l'appareil circulatoire Rodentia Sartan dérivé Système renin angiotensine Transferases Vertebrata
- Keyword (en)
- Atorvastatin Endothelium Hypertension Kinase Losartan Phosphatidylinositol Rat Dysfunction Endothelial dysfunction Angiotensin II Angiotensin antagonist Non peptide compound Imidazole derivatives Statin derivative Biphenyl derivatives Tetrazole derivatives Enzyme Peptide hormone Hydroxymethylglutaryl-CoA reductase HMG-CoA reductase inhibitor Enzyme inhibitor Mammalia Octapeptide Oxidoreductases Cardiovascular disease Rodentia Sartan derivatives Renin angiotensin system Transferases Vertebrata
- Keyword (es)
- Atorvastatina Endotelio Hipertensión arterial Kinase Losartán Fosfatidilinositol Rata Trastorno funcional Disfunción del endotelio Angiotensina II Antagonista angiotensina Compuesto no péptido Imidazol derivado Statina derivado Bifenilo derivado Tetrazol derivado Enzima Hormona péptido Hydroxymethylglutaryl-CoA reductase Inhibidor HMG-CoA reductase Inhibidor enzima Mammalia Octapéptido Oxidoreductases Aparato circulatorio patología Rodentia Sartan derivado Sistema renin angiotensina Transferases Vertebrata
- Classification
- Pascal
- 002 Biological and medical sciences / 002A Fundamental and applied biological sciences. Psychology / 002A16 Vertebrates: anatomy and physiology, studies on body, several organs or systems
- Discipline
- Vertebrates : anatomy and physiology, studies on body, several organs or systems
- Origin
- Inist-CNRS
- Database
- PASCAL
- INIST identifier
- 26220713
Sauf mention contraire ci-dessus, le contenu de cette notice bibliographique peut être utilisé dans le cadre d’une licence CC BY 4.0 Inist-CNRS / Unless otherwise stated above, the content of this bibliographic record may be used under a CC BY 4.0 licence by Inist-CNRS / A menos que se haya señalado antes, el contenido de este registro bibliográfico puede ser utilizado al amparo de una licencia CC BY 4.0 Inist-CNRS
Access to the document
Install on your browser
DOI
10.1139/y2012-089 
https://dx.doi.org/10.1139/y2012-089
"O:13:\"PanistOpenUrl\":36:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000idc\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:17:\"10.1139\/y2012-089\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:138:\"Effect of phosphatidylinositol 3-kinase-\u03b3 inhibitor CAY10505 in hypertension, and its associated vascular endothelium dysfunction in rats\";s:9:\"\u0000*\u0000jtitle\";s:47:\"Canadian journal of physiology and pharmacology\";s:9:\"\u0000*\u0000stitle\";s:26:\"Can. j. physiol. pharmacol\";s:7:\"\u0000*\u0000date\";s:4:\"2012\";s:9:\"\u0000*\u0000volume\";s:2:\"90\";s:8:\"\u0000*\u0000issue\";s:1:\"7\";s:8:\"\u0000*\u0000spage\";s:3:\"881\";s:8:\"\u0000*\u0000epage\";s:3:\"885\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0008-4212\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:5:\"TYAGI\";s:10:\"\u0000*\u0000aufirst\";s:7:\"Sandeep\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:2:{i:0;s:15:\"SHARMA, Saurabh\";i:1;s:20:\"RAMJI DASS BUDHIRAJA\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"CJPPA3\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:138:\"Effect of phosphatidylinositol 3-kinase-\u03b3 inhibitor CAY10505 in hypertension, and its associated vascular endothelium dysfunction in rats\";s:8:\"\u0000*\u0000place\";s:15:\"Plattsburgh, NY\";s:6:\"\u0000*\u0000pub\";s:35:\"National Research Council of Canada\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"5\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Panist access
"O:12:\"IstexOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:17:\"10.1139\/y2012-089\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:138:\"Effect of phosphatidylinositol 3-kinase-\u03b3 inhibitor CAY10505 in hypertension, and its associated vascular endothelium dysfunction in rats\";s:9:\"\u0000*\u0000jtitle\";s:47:\"Canadian journal of physiology and pharmacology\";s:9:\"\u0000*\u0000stitle\";s:26:\"Can. j. physiol. pharmacol\";s:7:\"\u0000*\u0000date\";s:4:\"2012\";s:9:\"\u0000*\u0000volume\";s:2:\"90\";s:8:\"\u0000*\u0000issue\";s:1:\"7\";s:8:\"\u0000*\u0000spage\";s:3:\"881\";s:8:\"\u0000*\u0000epage\";s:3:\"885\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0008-4212\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:5:\"TYAGI\";s:10:\"\u0000*\u0000aufirst\";s:7:\"Sandeep\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:2:{i:0;s:15:\"SHARMA, Saurabh\";i:1;s:20:\"RAMJI DASS BUDHIRAJA\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"CJPPA3\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:138:\"Effect of phosphatidylinositol 3-kinase-\u03b3 inhibitor CAY10505 in hypertension, and its associated vascular endothelium dysfunction in rats\";s:8:\"\u0000*\u0000place\";s:15:\"Plattsburgh, NY\";s:6:\"\u0000*\u0000pub\";s:35:\"National Research Council of Canada\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"5\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Istex access
"O:16:\"UnpaywallOpenUrl\":35:{s:8:\"\u0000*\u0000email\";s:27:\"assistance-portail@inist.fr\";s:6:\"\u0000*\u0000fmt\";N;s:6:\"\u0000*\u0000doi\";s:17:\"10.1139\/y2012-089\";s:6:\"\u0000*\u0000pii\";N;s:7:\"\u0000*\u0000pmid\";N;s:9:\"\u0000*\u0000atitle\";N;s:9:\"\u0000*\u0000jtitle\";N;s:9:\"\u0000*\u0000stitle\";N;s:7:\"\u0000*\u0000date\";N;s:9:\"\u0000*\u0000volume\";N;s:8:\"\u0000*\u0000issue\";N;s:8:\"\u0000*\u0000spage\";N;s:8:\"\u0000*\u0000epage\";N;s:8:\"\u0000*\u0000pages\";N;s:7:\"\u0000*\u0000issn\";N;s:8:\"\u0000*\u0000eissn\";N;s:9:\"\u0000*\u0000aulast\";N;s:10:\"\u0000*\u0000aufirst\";N;s:9:\"\u0000*\u0000auinit\";N;s:10:\"\u0000*\u0000auinitm\";N;s:5:\"\u0000*\u0000au\";N;s:9:\"\u0000*\u0000aucorp\";N;s:7:\"\u0000*\u0000isbn\";N;s:8:\"\u0000*\u0000coden\";N;s:8:\"\u0000*\u0000genre\";N;s:7:\"\u0000*\u0000part\";N;s:9:\"\u0000*\u0000btitle\";N;s:8:\"\u0000*\u0000title\";N;s:8:\"\u0000*\u0000place\";N;s:6:\"\u0000*\u0000pub\";N;s:10:\"\u0000*\u0000edition\";N;s:9:\"\u0000*\u0000tpages\";N;s:9:\"\u0000*\u0000series\";N;s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";N;}"
Unpaywall access
"O:16:\"EuropePMCOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:17:\"10.1139\/y2012-089\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:138:\"Effect of phosphatidylinositol 3-kinase-\u03b3 inhibitor CAY10505 in hypertension, and its associated vascular endothelium dysfunction in rats\";s:9:\"\u0000*\u0000jtitle\";s:47:\"Canadian journal of physiology and pharmacology\";s:9:\"\u0000*\u0000stitle\";s:26:\"Can. j. physiol. pharmacol\";s:7:\"\u0000*\u0000date\";s:4:\"2012\";s:9:\"\u0000*\u0000volume\";s:2:\"90\";s:8:\"\u0000*\u0000issue\";s:1:\"7\";s:8:\"\u0000*\u0000spage\";s:3:\"881\";s:8:\"\u0000*\u0000epage\";s:3:\"885\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0008-4212\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:5:\"TYAGI\";s:10:\"\u0000*\u0000aufirst\";s:7:\"Sandeep\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:2:{i:0;s:15:\"SHARMA, Saurabh\";i:1;s:20:\"RAMJI DASS BUDHIRAJA\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"CJPPA3\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:138:\"Effect of phosphatidylinositol 3-kinase-\u03b3 inhibitor CAY10505 in hypertension, and its associated vascular endothelium dysfunction in rats\";s:8:\"\u0000*\u0000place\";s:15:\"Plattsburgh, NY\";s:6:\"\u0000*\u0000pub\";s:35:\"National Research Council of Canada\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"5\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Europe PubMed Central access
"O:11:\"BaseOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:17:\"10.1139\/y2012-089\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:138:\"Effect of phosphatidylinositol 3-kinase-\u03b3 inhibitor CAY10505 in hypertension, and its associated vascular endothelium dysfunction in rats\";s:9:\"\u0000*\u0000jtitle\";s:47:\"Canadian journal of physiology and pharmacology\";s:9:\"\u0000*\u0000stitle\";s:26:\"Can. j. physiol. pharmacol\";s:7:\"\u0000*\u0000date\";s:4:\"2012\";s:9:\"\u0000*\u0000volume\";s:2:\"90\";s:8:\"\u0000*\u0000issue\";s:1:\"7\";s:8:\"\u0000*\u0000spage\";s:3:\"881\";s:8:\"\u0000*\u0000epage\";s:3:\"885\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0008-4212\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:5:\"TYAGI\";s:10:\"\u0000*\u0000aufirst\";s:7:\"Sandeep\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:2:{i:0;s:15:\"SHARMA, Saurabh\";i:1;s:20:\"RAMJI DASS BUDHIRAJA\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"CJPPA3\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:138:\"Effect of phosphatidylinositol 3-kinase-\u03b3 inhibitor CAY10505 in hypertension, and its associated vascular endothelium dysfunction in rats\";s:8:\"\u0000*\u0000place\";s:15:\"Plattsburgh, NY\";s:6:\"\u0000*\u0000pub\";s:35:\"National Research Council of Canada\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"5\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Base Search access
"O:12:\"ArXivOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:17:\"10.1139\/y2012-089\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:138:\"Effect of phosphatidylinositol 3-kinase-\u03b3 inhibitor CAY10505 in hypertension, and its associated vascular endothelium dysfunction in rats\";s:9:\"\u0000*\u0000jtitle\";s:47:\"Canadian journal of physiology and pharmacology\";s:9:\"\u0000*\u0000stitle\";s:26:\"Can. j. physiol. pharmacol\";s:7:\"\u0000*\u0000date\";s:4:\"2012\";s:9:\"\u0000*\u0000volume\";s:2:\"90\";s:8:\"\u0000*\u0000issue\";s:1:\"7\";s:8:\"\u0000*\u0000spage\";s:3:\"881\";s:8:\"\u0000*\u0000epage\";s:3:\"885\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0008-4212\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:5:\"TYAGI\";s:10:\"\u0000*\u0000aufirst\";s:7:\"Sandeep\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:2:{i:0;s:15:\"SHARMA, Saurabh\";i:1;s:20:\"RAMJI DASS BUDHIRAJA\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"CJPPA3\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:138:\"Effect of phosphatidylinositol 3-kinase-\u03b3 inhibitor CAY10505 in hypertension, and its associated vascular endothelium dysfunction in rats\";s:8:\"\u0000*\u0000place\";s:15:\"Plattsburgh, NY\";s:6:\"\u0000*\u0000pub\";s:35:\"National Research Council of Canada\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"5\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
arXiv access
